Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Cremoni

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
HLA|March 2, 2022
Overcoming barriers to widespread use of CAR-Treg therapy in organ transplant recipientsMarion Cremoni, Filippo Massa, Antoine Sicard
HLA|July 3, 2026
Characterisation of the Novel HLA-DQB1*03:618 Allele by Sequencing-Based TypingThibault Pajot, Isabelle Top, Marion Cremoni, et al.
Reproductive Biomedicine Online|March 2, 2026
Chronic air pollution exposure is associated with lower chance of live birth after frozen embryo transferAméline Crouzat, Marion Cremoni, Samir Boukaïdi, et al.
La Revue De Medecine Interne|November 6, 2025
[Anti-rituximab antibodies in autoimmune diseases and hematologic malignancies: An update]Maxime Teisseyre, Marco Allinovi, Michael Levraut, et al.
Kidney International Reports|March 30, 2026
Early-Stage B-cells Predict Relapse After Rituximab Treatment in Patients With Membranous NephropathyYousra Cheddadi, Mounir El Maï, Vesna Brglez, et al.
Renal Failure|March 27, 2025
Treatment of nephrotic syndrome with anti-CD20 therapies in pregnancy: a case series and review of the literaturePierre-Alexis Gauci, Marion Cremoni, Jérôme Delotte, et al.
BMJ Open|April 3, 2025
Artificial intelligence-based personalised rituximab treatment protocol in membranous nephropathy (iRITUX): protocol for a multicentre randomised control trialMaxime Teisseyre, Alexandre Destere, Marion Cremoni, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 25, 2022
Toxic Occupational Exposures and Membranous NephropathyMarion Cremoni, Sophie Agbekodo, Maxime Teisseyre, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 1, 2019
Rituximab bioavailability in primary membranous nephropathySonia Boyer-Suavet, Marine Andreani, Marion Cremoni, et al.
Frontiers in Immunology|November 1, 2021
Rituximab Immunomonitoring Predicts Remission in Membranous NephropathyMaxime Teisseyre, Marion Cremoni, Sonia Boyer-Suavet, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
HLA|March 2, 2022
Overcoming barriers to widespread use of CAR-Treg therapy in organ transplant recipientsMarion Cremoni, Filippo Massa, Antoine Sicard
HLA|July 3, 2026
Characterisation of the Novel HLA-DQB1*03:618 Allele by Sequencing-Based TypingThibault Pajot, Isabelle Top, Marion Cremoni, et al.
Reproductive Biomedicine Online|March 2, 2026
Chronic air pollution exposure is associated with lower chance of live birth after frozen embryo transferAméline Crouzat, Marion Cremoni, Samir Boukaïdi, et al.
La Revue De Medecine Interne|November 6, 2025
[Anti-rituximab antibodies in autoimmune diseases and hematologic malignancies: An update]Maxime Teisseyre, Marco Allinovi, Michael Levraut, et al.
Kidney International Reports|March 30, 2026
Early-Stage B-cells Predict Relapse After Rituximab Treatment in Patients With Membranous NephropathyYousra Cheddadi, Mounir El Maï, Vesna Brglez, et al.
Renal Failure|March 27, 2025
Treatment of nephrotic syndrome with anti-CD20 therapies in pregnancy: a case series and review of the literaturePierre-Alexis Gauci, Marion Cremoni, Jérôme Delotte, et al.
BMJ Open|April 3, 2025
Artificial intelligence-based personalised rituximab treatment protocol in membranous nephropathy (iRITUX): protocol for a multicentre randomised control trialMaxime Teisseyre, Alexandre Destere, Marion Cremoni, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 25, 2022
Toxic Occupational Exposures and Membranous NephropathyMarion Cremoni, Sophie Agbekodo, Maxime Teisseyre, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 1, 2019
Rituximab bioavailability in primary membranous nephropathySonia Boyer-Suavet, Marine Andreani, Marion Cremoni, et al.
Frontiers in Immunology|November 1, 2021
Rituximab Immunomonitoring Predicts Remission in Membranous NephropathyMaxime Teisseyre, Marion Cremoni, Sonia Boyer-Suavet, et al.
Pageof 4